The Novavax/Covovax “COVID-19 vaccine” is regarded as unsafe for children under 12 years of age by the World Health Organization (WHO) and the US Food and Drug Administration (FDA).
There is no publicly-available trial data for Novavax/Covovax and the MC Pharma “vaccines” that have been approved for children aged 3 – 12.
The vast majority of this young age group have already been exposed to SARS-CoV‑2 repeatedly, and have demonstrably effective immunity.
Children mount effective, robust, and sustained immune responses and clear the virus more easily than adults.
In the whole of 2020 and 2021, not a single child aged 1 – 9 died where COVID-19 was the sole diagnosis on the death certificate, according to ONS data.
A detailed study in England from 1 March 2020 to 1 March 2021 found only six children under 18 years died with no co-morbidities. There were no deaths aged 1 – 4.
Children are at statistically ZERO RISK from dying of COVID-19.
The virulence of virus variants has waned significantly – NO “VACCINES” ARE NECESSARY.
The efficacy of COVID-19 “vaccines” is negligible to the point of being questionable and wanes rapidly.
Pfizer never even tested their ‘COVID-19 vaccine” for transmission!
There are increasing concerns over long-term “COVID-19 vaccine” harms.
54,697 adverse event reports received for children (out of 1,394,703 reports) through August 26, 2022, for conditions such as encephalitis, Bell’s palsy, aneurysms, cerebral hemorrhage, myocarditis, thrombocytopenia, Guillain-Barré syndrome, appendicitis, heart disease, and death.
In the Pfizer study, 50% of “vaccinated” children had systemic adverse events.
PFizer is not due to report results on post-authorization conditions (5 – 11s) until 2027.
Myocarditis in adolescents and young adults, especially in males after the second dose, is high. The emerging evidence of persistent cardiac abnormalities in adolescents with post-mRNA vaccine myopericarditis suggests this is far from ‘mild and short-lived’.
Researchers from Thailand published a new preprint on 8 August that enrolled 13 – 18 year olds (202 boys, 99 girls) who received a second dose of Pfizer’s mRNA “COVID-19 vaccine” after getting the first dose without adverse events.
This is exactly the kind of study the FDA claimed it wanted Pfizer to do.
Unfortunately, the results are not reassuring.
Three patients were admitted to the hospital who had chest pain and biomarker elevation. Four patients had no chest pain but elevated cardiac biomarkers. These were all in boys.
That means 7/202 boys (1 in 29) ages 13 to 18 had overt or subclinical myocarditis after the second mRNA does, even if they experienced no adverse events after the first mRNA dose.
The potential for longer term effects requires further study and calls for the precautionary principle to be applied.
Post “COVID-19 vaccination” myocarditis appears to be less common in 5 – 11-year-olds than older children, it is, nonetheless, increased over baseline.
Of equal concern are, as yet unknown, negative effects on the innate immune system. There is evidence of “COVID-19 vaccine” induced disruption of both innate and adaptive immune responses. The possibility of developing an impaired immune function would be disastrous for children, who have the most competent innate immunity, which by now has been effectively trained by the circulating virus.
In the 0 – 4s trial, less than 10 children participated. These figures are much too small to rule out any adverse impact such as antibody dependent enhancement (ADE) and other impacts on the immune system.
The innate (cellular) immune system acts as the first line of defense against pathogens and exposure to pathogens is essential to its development.
When children are given an mRNA “vaccine” their innate immune systems do not learn how to respond. The “vaccine” antibodies bind to the virus’s spike protein and prevent the immune system from doing its job.
The immune system does not learn how to differentiate between a normal cell and a pathogen, leading autoimmune disorders.
Also unanswered is the question of Original Antigenic Sin. In a large Israeli study, those infected after “vaccination” had poorer cover than those “vaccinated” after infection. In the Moderna trial, N‑antibodies were seen in only 40% of those infected after vaccination, compared with 93% of those infected after placebo.
Changes to the immune system could cause the proliferation of cancer cells.
“COVID-19 vaccination” causes a significant change in type 1 interferon (INF type 1) signalling and plays a critical role in both controlling viral proliferation and inducing antibody production. INF 1 cells are essential in stopping the growth of virus and cancer cells.
Totally unknown is whether there will be any adverse effect on T‑cell function leading to an increase in cancers.
Also, in terms of reproductive function, limited animal bio-distribution studies showed lipid nanoparticles concentrate in ovaries and testes. Adult sperm donors have showed a reduction in sperm counts particularly of motile sperm, falling by three months post-vaccination and remaining depressed at four to five months.
Even for adults, concerns are rising that serious adverse events are in excess of hospitalizations from “COVID-19”.
Risk is higher than benefit. Due to all of the above, the claims with regard to balance of benefit and risk which supported the rollout of mRNA vaccines to the elderly and vulnerable in 2021 is totally inappropriate for small children in 2022.
Pfizer documentation presented to the FDA is problematic and protocol was irregular. Dosages were changed, decisions were made on groups with as few as 3 trial participants.
Safety data is insufficient. Of the 1,057 children participating in the trials, some were unblinded, and all were followed for just two months.
Many countries have prohibited or do not recommend the “COVID-19 vaccines” for children.
The UK is now no longer allowing children under the age of 11 to be “vaccinated” for “COVID-19”. The State of Florida does not recommend “COVID-19 vaccines” to 18 – 39-year-old males, nor for any children under 18. Sweden is no longer recommending “COVID-19 vaccines” for children aged under 18. Norway is not recommending “COVID-19 vaccines” for 5 – 11s, Holland is not recommending “vaccination” for children who have already had “COVID-19”. The director of the Danish Health and Medicines Authority recently stated that with what is now known, the decision to “vaccinate” children for “COVID-19” was a mistake and has prohibited “COVID-19 vaccines” for children under 18 years of age.
There is no proper Informed consent
There can be no proper informed consent without proper information. There is no long-term safety data for chronic disease eg cancer which can take up to 11 years as conditions like these don’t just pop up overnight.
There can be no proper informed consent when ingredients and method are unknown.
There is complete omission of information explaining to the public the different and novel technology used in “COVID-19 vaccines” compared to standard vaccines.
In fact, the failure to inform of the lack of any long-term safety data and the above is more like disinformation.